Tove’ Bolken shares perspective on what biopharmaceutical companies can expect in manufacturing for 2021 and beyond
Tove’ Bolken shares perspective on what biopharmaceutical companies can expect in manufacturing for 2021 and beyond
November 30, 2020 at 12:00 PM EST